Upexi (UPXI) to Release Quarterly Earnings on Tuesday

Upexi (NASDAQ:UPXI) is expected to be announcing its Q1 2026 results before the market opens on Tuesday, November 11th. Analysts expect the company to announce earnings of ($0.01) per share and revenue of $7.3280 million for the quarter. Individuals can check the company’s upcoming Q1 2026 earningsummary page for the latest details on the call scheduled for Tuesday, November 11, 2025 at 5:30 PM ET.

Upexi Price Performance

NASDAQ UPXI opened at $3.31 on Monday. Upexi has a twelve month low of $1.90 and a twelve month high of $22.57. The stock has a market cap of $194.93 million, a P/E ratio of -0.58 and a beta of -0.56. The company’s 50-day simple moving average is $5.72 and its 200 day simple moving average is $7.38.

Institutional Investors Weigh In On Upexi

A hedge fund recently raised its stake in Upexi stock. Vanguard Group Inc. lifted its stake in shares of Upexi, Inc. (NASDAQ:UPXI) by 41.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 710,744 shares of the company’s stock after purchasing an additional 209,907 shares during the period. Vanguard Group Inc. owned approximately 1.21% of Upexi worth $4,101,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 5.68% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on UPXI shares. Cantor Fitzgerald raised Upexi to a “strong-buy” rating in a report on Wednesday, August 13th. Alliance Global Partners began coverage on Upexi in a research note on Monday, August 4th. They set a “buy” rating and a $15.00 price objective for the company. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Upexi in a research note on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Upexi presently has an average rating of “Moderate Buy” and an average price target of $15.50.

Upexi Company Profile

Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.